Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Jens F. Rehfeld; Filip K. Knop; Ali Asmar; Sten Madsbad; Jens J. Holst; Meena Asmar

doi:10.1080/00365521.2018.1530297

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Jens F. Rehfeld, Filip K. Knop, Ali Asmar, Sten Madsbad, Jens J. Holst, Meena Asmar

Department of Clinical Medicine

7 Citations (Scopus)

Original language	English
Book series	Scandinavian Journal of Gastroenterology
Volume	53
Issue number	12
Pages (from-to)	1429-1432
ISSN	0036-5521
DOIs	https://doi.org/10.1080/00365521.2018.1530297
Publication status	Published - 2 Dec 2018

Keywords

Cholecystokinin
cholecystitis
cholelithiasis
diabetes mellitus
glucagon-like peptide 1
side effects

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/00365521.2018.1530297

Cite this

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs. / Rehfeld, Jens F.; Knop, Filip K.; Asmar, Ali et al.
In: Scandinavian Journal of Gastroenterology, Vol. 53, No. 12, 02.12.2018, p. 1429-1432.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{9090b7ad4e7c4499a84bc4b27219d2ed,

title = "Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs",

keywords = "Cholecystokinin, cholecystitis, cholelithiasis, diabetes mellitus, glucagon-like peptide 1, side effects",

author = "Rehfeld, {Jens F.} and Knop, {Filip K.} and Ali Asmar and Sten Madsbad and Holst, {Jens J.} and Meena Asmar",

year = "2018",

month = dec,

day = "2",

doi = "10.1080/00365521.2018.1530297",

language = "English",

volume = "53",

pages = "1429--1432",

journal = "Scandinavian Journal of Gastroenterology",

issn = "0036-5521",

publisher = "Taylor & Francis",

number = "12",

}

TY - JOUR

T1 - Cholecystokinin secretion is suppressed by glucagon-like peptide-1

T2 - clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

AU - Rehfeld, Jens F.

AU - Knop, Filip K.

AU - Asmar, Ali

AU - Madsbad, Sten

AU - Holst, Jens J.

AU - Asmar, Meena

PY - 2018/12/2

Y1 - 2018/12/2

KW - Cholecystokinin

KW - cholecystitis

KW - cholelithiasis

KW - diabetes mellitus

KW - glucagon-like peptide 1

KW - side effects

U2 - 10.1080/00365521.2018.1530297

DO - 10.1080/00365521.2018.1530297

M3 - Journal article

C2 - 30449207

SN - 0036-5521

VL - 53

SP - 1429

EP - 1432

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

IS - 12

ER -

Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugs

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this